Please use this identifier to cite or link to this item: https://doi.org/10.1182/blood-2010-08-301283
DC FieldValue
dc.titleThe small GTPase Rac1 is a novel binding partner of Bcl-2 and stabilizes its antiapoptotic activity
dc.contributor.authorVelaithan, R.
dc.contributor.authorKang, J.
dc.contributor.authorHirpara, J.L.
dc.contributor.authorLoh, T.
dc.contributor.authorGoh, B.C.
dc.contributor.authorLe Bras, M.
dc.contributor.authorBrenner, C.
dc.contributor.authorClement, M.-V.
dc.contributor.authorPervaiz, S.
dc.date.accessioned2014-11-26T07:49:02Z
dc.date.available2014-11-26T07:49:02Z
dc.date.issued2011-06-09
dc.identifier.citationVelaithan, R., Kang, J., Hirpara, J.L., Loh, T., Goh, B.C., Le Bras, M., Brenner, C., Clement, M.-V., Pervaiz, S. (2011-06-09). The small GTPase Rac1 is a novel binding partner of Bcl-2 and stabilizes its antiapoptotic activity. Blood 117 (23) : 6214-6226. ScholarBank@NUS Repository. https://doi.org/10.1182/blood-2010-08-301283
dc.identifier.issn00064971
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/109708
dc.description.abstractThe small GTPase Rac1 is involved in the activation of the reduced NAD phosphate oxidase complex resulting in superoxide production.We recently showed that Bcl-2 overexpression inhibited apoptosis in leukemia cells by creating a pro-oxidant intracellular milieu, and that inhibiting intracellular superoxide production sensitized Bcl-2-overexpressing cells to apoptotic stimuli. We report here that silencing and functional inhibition of Rac1 block Bcl-2- mediated increase in intracellular superoxide levels in tumor cells. Using confocal, electron microscopy and coimmunoprecipitation, as well as glutathione S-transferase- fusion proteins, we provide evidence for a colocalization and physical interaction between the 2 proteins. This interaction is blocked in vitro and in vivo by the BH3 mimetics as well as by synthetic Bcl-2 BH3 domain peptides. That this interaction is functionally relevant is supported by the ability of the Bcl-2BH3peptide as well as the silencing and functional inhibition of Rac1 to inhibit intracellular superoxide production as well as overcome Bcl-2-mediated drug resistance in human leukemia cells and cervical cancer cells. Notably, the interaction was observed in primary cells derived from patients with B-cell lymphoma overexpressing Bcl-2 but not in noncancerous tissue. These data provide a novel facet in the biology of Bcl-2 with potential implications for targeted anticancer drug design. © 2011 by The American Society of Hematology.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1182/blood-2010-08-301283
dc.sourceScopus
dc.typeArticle
dc.contributor.departmentCANCER SCIENCE INSTITUTE OF SINGAPORE
dc.contributor.departmentBIOCHEMISTRY
dc.description.doi10.1182/blood-2010-08-301283
dc.description.sourcetitleBlood
dc.description.volume117
dc.description.issue23
dc.description.page6214-6226
dc.description.codenBLOOA
dc.identifier.isiut000291438000023
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

50
checked on Aug 14, 2020

WEB OF SCIENCETM
Citations

51
checked on Aug 14, 2020

Page view(s)

94
checked on Aug 1, 2020

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.